Insights

article

Game (not) over for computer-implemented inventions

article

Shifting the starting line: regulatory changes to impact Australian pharma patent disputes

article

COVID-19: when do private patent rights give way to the public interest?

article

A lost opportunity? Full Federal Court holds that mere ‘abstract ideas’ using ‘generic computer technology’ lack patentability

article

A turning of the tide: interlocutory injunctions in Australian pharma patent cases

article

Could proposed amendments to IP laws change how governments can use patented inventions under ‘Crown use’ rights?

article

Key IP enforcement tool likely to be abolished: time to act now

article

Power and purpose: Protecting a competitive position after ACCC v Pfizer (II)

article

Change in the air for IP laws in Australia: 5 key takeaways